Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/

Accepted 2022-06-27 00:00:00 ET · period of report 2022-06-23 · accession 0001775052-22-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-27	2022-06-23	KEQU	Gardner Donald T. III	CFO	M - OptEx	$0.00	+1,419	10.6K	+15%	$0
D	2022-06-27	2022-06-23	KEQU	Gardner Donald T. III	CFO	F - Tax	$13.82	-405	10.2K	-4%	-$5,597
D	2022-06-27	2022-06-23	KEQU	Gardner Donald T. III	CFO	M - OptEx	$0.00	-1,419	7,801	-15%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-23	M	A	1,419	$0.00	10,575	D	—	—	(F1) Restricted stock units convert to common stock on a one-for-one basis.
2	Common	Common Stock	2022-06-23	F	D	405	$13.82	10,170	D	—	—
3	Derivative	Restricted Stock Units FY21	2022-06-23	M	D	1,419	$0.00	7,801	D	— · — to —	1,419 Common Stock	(F1) Restricted stock units convert to common stock on a one-for-one basis. (F2) On June 23, 2020, the reporting person was granted restricted stock units that vest as follows: (a) 40% of the number of restricted stock units subject to the award consist of service-based restricted stock units that vest in three equal annual installments beginning on June 23, 2021, subject to the reporting person's continued employment with the Company, and (b) 60% of the number of restricted stock units subject to the award consist of performance-based restricted stock units that vest only if performance goals are achieved over a three-year period. The actual number of units (if any) received under this award will depend on continued employment and actual performance over the three-year performance period.